Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163.
暂无分享,去创建一个
Vladimir P Torchilin | S. Moestrup | H. Møller | V. Torchilin | J. Graversen | Anders Etzerodt | Maciej Bogdan Maniecki | Jonas Heilskov Graversen | Holger Jon Møller | Søren Kragh Moestrup | Anders Etzerodt | M. Maniecki | A. Etzerodt
[1] S. Lee,et al. Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80 , 1985, The Journal of experimental medicine.
[2] M. Kurrer,et al. Soluble hemoglobin–haptoglobin scavenger receptor CD163 as a lineage‐specific marker in the reactive hemophagocytic syndrome , 2005, European journal of haematology.
[3] R. Lutter,et al. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. , 2009, Arthritis and rheumatism.
[4] M. Hope,et al. Contact hypersensitivity: a simple model for the characterization of disease-site targeting by liposomes. , 1999, Biochimica et biophysica acta.
[5] R. Schiffelers,et al. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. , 2008, Neoplasia.
[6] Theresa M Allen,et al. Advantages of liposomal delivery systems for anthracyclines. , 2004, Seminars in oncology.
[7] S. Moestrup,et al. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. , 2004, Arthritis and rheumatism.
[8] P. Wallace,et al. Endotoxin induces rapid metalloproteinase‐mediated shedding followed by up‐regulation of the monocyte hemoglobin scavenger receptor CD163 , 2002, Journal of leukocyte biology.
[9] P. Tak,et al. Macrophage Subsets in Immune-Mediated Inflammatory Disease: Lessons from Rheumatoid Arthritis, Spondyloarthritis, Osteoarthitis, Behçet’s Disease and Gout , 2010 .
[10] P. Low,et al. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. , 1994, The Journal of biological chemistry.
[11] T. Allen,et al. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.
[12] G. Burmester,et al. Macrophages in rheumatoid arthritis , 2000, Arthritis research.
[13] R. Voegeli,et al. A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. , 1987, Experimental cell biology.
[14] V. Torchilin. Antibody-modified liposomes for cancer chemotherapy , 2008, Expert opinion on drug delivery.
[15] J. Calvert,et al. CD163 Expression Confers Susceptibility to Porcine Reproductive and Respiratory Syndrome Viruses , 2007, Journal of Virology.
[16] W. Jessup,et al. The macrophage in atherosclerosis: modulation of cell function by sterols , 1999, Journal of leukocyte biology.
[17] A. Palmer,et al. Liposomes surface conjugated with human hemoglobin target delivery to macrophages , 2012, Biotechnology and bioengineering.
[18] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[19] J. Enghild,et al. A Unique Loop Extension in the Serine Protease Domain of Haptoglobin Is Essential for CD163 Recognition of the Haptoglobin-Hemoglobin Complex* , 2007, Journal of Biological Chemistry.
[20] R. Schiffelers,et al. Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil , 2008, Pharmaceutical Research.
[21] A. Lamprecht,et al. Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases , 2010, Journal of The Royal Society Interface.
[22] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[23] T. Langmann,et al. The Scavenger Receptor CD163: Regulation, Promoter Structure and Genomic Organization , 2000, Pathobiology.
[24] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[25] E. Jordanova,et al. Detection of M2-macrophages in uveal melanoma and relation with survival. , 2011, Investigative ophthalmology & visual science.
[26] A. Sica,et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. , 2009, Blood.
[27] P. Gómez-Puertas,et al. Expression of porcine CD163 on monocytes/macrophages correlates with permissiveness to African swine fever infection , 2003, Archives of Virology.
[28] T. K. van den Berg,et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. , 2009, Blood.
[29] S. Moestrup,et al. Tumor necrosis factor -converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163 , 2010 .
[30] K. Mann,et al. A two-component drug delivery system using Her-2-targeting thermosensitive liposomes , 2009, Journal of drug targeting.
[31] Martine De Vos,et al. Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed and stimulate proteoglycan synthesis in healthy and osteoarthritic human articular chondrocytes , 2001, Arthritis Research.
[32] J C Stewart,et al. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. , 1980, Analytical biochemistry.
[33] H. Segal,et al. Uptake of free hemoglobin by rat liver parenchymal cells. , 1984, Biochemical and biophysical research communications.
[34] J. Fonseca,et al. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments. , 2002, Arthritis and rheumatism.
[35] A. Allison,et al. The macrophage as a secretory cell in chronic inflammation , 1976, Agents and Actions.
[36] H. Møller,et al. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] S. Moestrup,et al. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression. , 2011, Immunobiology.
[38] T. K. van den Berg,et al. CD163‐positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation , 2005, Glia.
[39] P. Guyre,et al. TGF‐β regulation of human macrophage scavenger receptor CD163 is Smad3‐dependent , 2004 .
[40] A. Mantovani,et al. The origin and function of tumor-associated macrophages. , 1992, Immunology today.
[41] A. Sica,et al. Tumor promotion by tumor-associated macrophages. , 2007, Advances in experimental medicine and biology.
[42] S. McCarthy,et al. A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-MAC3, Ki-M8 and SM4. , 1992, Immunology.
[43] A. Puig-Kröger,et al. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. , 2009, Cancer research.
[44] B. Aggarwal,et al. A Previously Unrecognized Protein-Protein Interaction between TWEAK and CD163: Potential Biological Implications1 , 2007, The Journal of Immunology.
[45] Nalin Rastogi,et al. Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. , 2000, Microbial pathogenesis.
[46] T. K. van den Berg,et al. The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. , 2006, Immunobiology.
[47] G. Berry. Thermodynamic and Conformational Properties of Polystyrene. I. Light‐Scattering Studies on Dilute Solutions of Linear Polystyrenes , 1966 .
[48] D. Mosser,et al. The many faces of macrophage activation , 2003, Journal of leukocyte biology.
[49] V. Torchilin,et al. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.
[50] Yi-Chen Lin,et al. Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] D. Baeten,et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy , 2005, Arthritis research & therapy.
[52] P. Högger,et al. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. , 1999, Biochemical and biophysical research communications.
[53] R. Crofton,et al. The origin, kinetics, and characteristics of the kupffer cells in the normal steady state , 1978, The Journal of experimental medicine.
[54] T. Langmann,et al. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.
[55] H. Yanagie,et al. Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In Vivo , 2001, Pharmaceutical Research.
[56] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[57] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[58] G. Kuttan,et al. Role of macrophages in tumour progression. , 2009, Immunology letters.
[59] Y. Mahida. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease , 2000 .
[60] S. Moestrup,et al. CD163: a regulated hemoglobin scavenger receptor with a role in the anti‐inflammatory response , 2004, Annals of medicine.
[61] L. Boon,et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. , 2004, American journal of clinical pathology.
[62] S. Moestrup,et al. The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. , 2007, Blood.
[63] J. Orenstein,et al. The macrophage in HIV infection. , 2001, Immunobiology.